Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Higher titers of anti-Saccharomyces cerevisiae antibodies IgA and IgG are associated with more aggressive phenotypes in Romanian patients with Crohn's disease.

Journal of gastrointestinal and liver diseases : JGLD - 1 Mar 2012

Gologan Serban, Iacob Razvan, Preda Carmen, Vadan Roxana, Cotruta Bogdan, Catuneanu Ana-Maria, Iacob Speranta, Constantinescu Ileana, Gheorghe Liana, Iobagiu Silviu, Gheorghe Cristian, Diculescu Mircea

Abstract excerpt

BACKGROUND AND AIMS: Serological markers have been widely used for diagnostic purposes and disease stratification in inflammatory bowel diseases (IBD). The aim of this study was to investigate the seroprevalence and the correlations of anti-Saccharomyces cerevisiae antibodies (ASCA) titers with different clinical phenotypes in Romanian patients with Crohn's disease (CD). METHODS: The study included 107 CD and 86...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Fungal
Share to Colitis, Ulcerative

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Crohn Disease

Share to Enzyme-Linked Immunosorbent Assay

Share to Immunoglobulin A

Share to Immunoglobulin G

Share to Romania

Share to Seroepidemiologic Studies

Source

Identifiers

PMID: 22457858

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Higher titers of anti-Saccharomyces cerevisiae antibodies IgA and IgG are associated with more aggressive phenotypes in Romanian patients with Crohn's disease.PMID 22457858Read ↗

Significance of anti-sacharomices cerevisiae antibodies (ASCA) in patients with inflammatory bowel diseases in Romania.Semantic proximity Read ↗

Anti-Saccharomyces cerevisiae antibodies status is associated with oral involvement and disease severity in Crohn disease.Semantic proximity Read ↗

Clinical significance of anti-Saccharomyces cerevisiae antibody (ASCA) in Korean patients with Crohn's disease and its relationship to the disease clinical course.Semantic proximity Read ↗

Anti-Saccharomyces cerevisiae antibodies associate with phenotypes and higher risk for surgery in Crohn's disease: a meta-analysis.Semantic proximity Read ↗

Variation of Gut Mucosal Microbiome With Anti‐Saccharomyces cerevisiae Antibody Status in Pediatric Crohn DiseaseSemantic proximity Read ↗

Diagnostic utility, disease activity, and disease phenotype correlation of serum ASCA, pANCA, and PR3-ANCA in pediatric inflammatory bowel disease.Semantic proximity Read ↗

Serologic markers: impact on early diagnosis and disease stratification in inflammatory bowel disease.Semantic proximity Read ↗

Serological studies in inflammatory bowel disease: how important are they?Semantic proximity Read ↗

Association of Anti-Saccharomyces cerevisiae antibodies with clinical phenotype in spondyloarthritis patients.Semantic proximity Read ↗

[Diagnostic value of different serological markers and correlation analysis with disease phenotype in inflammatory bowel disease].Semantic proximity Read ↗

Anti-saccharomyces cerevisiae antibodies in patients with inflammatory bowel disease and their first-degree relatives: potential clinical value.Semantic proximity Read ↗

Anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease are associated with disease severity but not NOD2/CARD15 mutations.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.